Penicillin G Procaine: Difference between revisions
Ostermayer (talk | contribs) (Text replacement - "Category:Drugs" to "Category:Pharmacology") |
(Add AntibioticDose SMW query table for dynamic indications by disease) |
||
| (6 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
==General== | ==General== | ||
*Type: Natural [[Penicillin]] | *Type: Natural [[Penicillin]] | ||
* | *Routes of Administration: IM | ||
*Common Trade Names: | *Common Trade Names: | ||
| Line 16: | Line 16: | ||
===Neurosyphilis=== | ===Neurosyphilis=== | ||
*2.4 million units/day IM + | *2.4 million units/day IM + 500mg probenecid PO QID x 10-14 days | ||
*Info: [[Penicillin G]] aqueous I.V. is preferred | *Info: [[Penicillin G]] aqueous I.V. is preferred | ||
| Line 22: | Line 22: | ||
*1.2 million units/day + streptomycin x 10-14 days | *1.2 million units/day + streptomycin x 10-14 days | ||
*Followed by [[trimethoprim/sulfamethoxazole]] or doxycycline x 1 year | *Followed by [[trimethoprim/sulfamethoxazole]] or doxycycline x 1 year | ||
===Indications by Disease=== | |||
{{#ask: [[Has DrugName::Penicillin G Procaine]] [[Has Population::Adult]] | |||
|?Treats disease=Disease | |||
|?Has Dose=Dose | |||
|?Has Context=Context | |||
|format=table | |||
|limit=50 | |||
|mainlabel=- | |||
|headers=show | |||
|sort=Treats disease | |||
}} | |||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
''Avoid use in neonates: increased risk of sterile abscesses and procaine reactions'' | |||
===Indications by Disease=== | |||
{{#ask: [[Has DrugName::Penicillin G Procaine]] [[Has Population::Pediatric]] | |||
|?Treats disease=Disease | |||
|?Has Dose=Dose | |||
|?Has Context=Context | |||
|format=table | |||
|limit=50 | |||
|mainlabel=- | |||
|headers=show | |||
|sort=Treats disease | |||
}} | |||
===General=== | ===General=== | ||
*25,000-50,000 units/kg/day divided 1-2 times/day | *25,000-50,000 units/kg/day divided 1-2 times/day | ||
| Line 51: | Line 77: | ||
==Contraindications== | ==Contraindications== | ||
*Allergy to class/drug | *Allergy to class/drug | ||
*Avoid use in neonates | |||
==Adverse Reactions== | ==Adverse Reactions== | ||
===Serious=== | ===Serious=== | ||
*Procaine reactions: Immediate toxic reactions, particularly when a large single dose is administered (4.8 million units); mental disturbances including anxiety, confusion, agitation, depression, weakness, seizures, hallucinations, combativeness, and fear | |||
*Jarisch-Herxheimer reaction with syphilis treatment | |||
*Pseudomembranous colitis | |||
===Common=== | ===Common=== | ||
*Rash, urticaria, exfoliative dermatitis | |||
*Serum-sickness like reaction | |||
==Pharmacology== | ==Pharmacology== | ||
*Half-life: | *Half-life: 30m | ||
*Metabolism: | *Metabolism: Hepatic | ||
*Excretion: | *Excretion: Urinary | ||
*Mechanism of Action: | *Mechanism of Action: Bactericidal; Interferes with cell wall mucopeptide synthesis during active multiplication | ||
==See Also== | ==See Also== | ||
*[[Antibiotics (Main)]] | *[[Antibiotics (Main)]] | ||
== | ==References== | ||
<references/> | <references/> | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
[[Category:ID]] | |||
Latest revision as of 20:38, 20 March 2026
General
- Type: Natural Penicillin
- Routes of Administration: IM
- Common Trade Names:
Adult Dosing
Anthrax
- Inhalational (Postexposure Prophylaxis)
- 1,200,000 units IM q12 hours x 60 days (see below)
- Info: Total treatment duration = 60 days. Do not give IM for over 2 weeks, switching alternative treatment to complete course
- Cutaneous, Nonsevere (Treatment)
- 600,000-1,200,000 units/day IM
Endocarditis by susceptible Streptococcus viridans
- 1.2 million units IM q6 hours x 2-4 weeks + aminoglycoside
Neurosyphilis
- 2.4 million units/day IM + 500mg probenecid PO QID x 10-14 days
- Info: Penicillin G aqueous I.V. is preferred
Whipple's Disease
- 1.2 million units/day + streptomycin x 10-14 days
- Followed by trimethoprim/sulfamethoxazole or doxycycline x 1 year
Indications by Disease
| Disease | Dose | Context |
|---|---|---|
| Syphilis | 2.4 million units IM daily | Neurosyphilis |
Pediatric Dosing
Avoid use in neonates: increased risk of sterile abscesses and procaine reactions
Indications by Disease
| Disease | Dose | Context |
|---|---|---|
| Diphtheria | 300,000 U/day IM (≤10 kg) or 600,000 U/day IM (>10 kg) x14 days | |
| Syphilis | 50,000 units/kg IM daily x 10-14 days | Congenital Syphilis alt |
General
- 25,000-50,000 units/kg/day divided 1-2 times/day
- First Dose: 25,000-50,000 units/kg x 1
- Max: 4.8 million units/day
Anthrax
- Inhalational (postexposure prophylaxis)
- 25,000 units/kg IM q12 hours
- Max: 1,200,000 units q12 hours
- Info: Total treatment duration = 60 days. Do not give IM for over 2 weeks, switching alternative treatment to complete course
Syphilis (Congenital)
- 50,000 units/kg/day IM daily x 10 days
- If >1 day of therapy is missed, restart entire course of treatment
Special Populations
- Pregnancy Category: B
- Lactation: Use caution
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
- Avoid use in neonates
Adverse Reactions
Serious
- Procaine reactions: Immediate toxic reactions, particularly when a large single dose is administered (4.8 million units); mental disturbances including anxiety, confusion, agitation, depression, weakness, seizures, hallucinations, combativeness, and fear
- Jarisch-Herxheimer reaction with syphilis treatment
- Pseudomembranous colitis
Common
- Rash, urticaria, exfoliative dermatitis
- Serum-sickness like reaction
Pharmacology
- Half-life: 30m
- Metabolism: Hepatic
- Excretion: Urinary
- Mechanism of Action: Bactericidal; Interferes with cell wall mucopeptide synthesis during active multiplication